Abstract
For legal reasons, the publisher has withdrawn permission for online, public display of this record in PubMed. For additional information, please contact the publisher.
Keywords:
COVID-19; coronavirus; medication; pneumonia; treatment.
© 2020 Journal of Population Therapeutics and Clinical Pharmacology. All rights reserved.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use*
-
Azithromycin / administration & dosage
-
Azithromycin / adverse effects
-
Azithromycin / therapeutic use*
-
Betacoronavirus
-
Bronchoalveolar Lavage Fluid / virology
-
COVID-19
-
Coronavirus Infections / complications*
-
Female
-
Humans
-
Lincomycin / administration & dosage
-
Lincomycin / adverse effects
-
Lincomycin / therapeutic use*
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / etiology
-
Pneumonia, Viral / virology
-
Prospective Studies
-
Risk Factors
-
SARS-CoV-2
Substances
-
Anti-Bacterial Agents
-
Azithromycin
-
Lincomycin